Clinical trial · Interventional
Microwave Ablation for Pulmonary Metastases From Colorectal Cancer
CT-guided Percutaneous Microwave Ablation for Pulmonary Metastases From Colorectal Cancer
NCT02502630CI-TRIAL-00023496completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
(MWA) is the most recent development in the field of local ablative therapies. The aim of this study was to evaluate CT-guided percutaneous microwave (MW) ablation safety and efficacy in pulmonary metastases from colorectal cancer.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colorectal Cancer | Malignant Colorectal Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| microwave ablation | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Treated with microwave ablation
- description
- Patients undergoing MWA for pulmonary metastases from colorectal cancer.
- interventionNames
- Device: microwave ablation
Primary outcomes (1)
- measure
- Overall Survival (OS)
- timeFrame
- one year
Secondary outcomes (1)
- measure
- Treatment related adverse events
- timeFrame
- Eight weeks
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 75 Years
Show eligibility criteria text
Inclusion Criteria: * Unresectable pulmonary metastases from colorectal cancer. * diagnosis by CT, and confirmed by percutaneous puncture biopsy. * Age range 18-70 years old. * Eastern Cooperative Oncology Group performance status 0-1. * Life expectancy of more than 3 months. * Adequate organ function. Exclusion Criteria: * Resectable lung metastases. * Life expectancy less than 3 months * Patients with cardiac pacemaker, cerebral aneurysm clips, implanted electronic instruments or other metal materials. * Coagulopathy with platelet count less than 50000. * Active infectious disease. * Age below 18 years. * Pregnancy of breastfeeding.
References
Publications (1)
- DERIVEDCheng G, Shi L, Qiang W, Wu J, Ji M, Lu Q, Li X, Xu B, Jiang J, Wu C. The safety and efficacy of microwave ablation for the treatment of CRC pulmonary metastases. Int J Hyperthermia. 2018 Jun;34(4):486-491. doi: 10.1080/02656736.2017.1366553. Epub 2017 Nov 16. PMID 28847194